Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy
Part of paid clinical trials in Duarte, California.
- Sponsor
- Children's Oncology Group
- Study ID
- NCT00006095
- Phase
- PHASE1
- Status
- Completed
Conditions
- Unspecified Childhood Solid Tumor, Protocol Specific
Eligibility Criteria
- Sex
- ALL
- Age
- 1 Year - 21 Years
- Healthy Volunteers
- Not accepted
Interventions
- irinotecan hydrochloride — DRUG
- vincristine sulfate — DRUG
Study Details
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of vincristine plus irinotecan in treating children who have solid tumors that have not responded to previous therapy.
Key Dates
- Start date
- Jul 31, 2000
- Status verified
- Feb 2014
- Primary completion
- Jan 31, 2005
- Completion
- Sep 30, 2005
Study Design
- Enrollment
- 20 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Vincristine Sulfate 1.5 mg/m2/wk and Irinotecan
- Experimental: Vincristine sulfate 2.0 mg/m2/wk and Irinotecan
Primary Outcome Measure
Progression Free Survival [ Time Frame: Length of study ]
Locations (21)
Find similar trials in Duarte, CA
By research site
Cancer Center and Beckman Research Institute, City of Hope· Duarte, CAChildren's Hospital Los Angeles· Los Angeles, CAJonsson Comprehensive Cancer Center, UCLA· Los Angeles, CAChildren's Hospital of Orange County· Orange, CAUCSF Cancer Center and Cancer Research Institute· San Francisco, CAChildren's National Medical Center· Washington D.C., DC
Related Studies
- Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid TumorsRecruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina